| Ytd | -19.96% | |
| 1y | -28.82% |
| Open | 3.91 | Prev Close | 3.90 | Low | 3.90 | High | 4.10 | Mkt Cap | 25.47M |
| Vol | 38.24K | Avg Vol | 67.06K | EPS | -3.42 | P/E | -1.18 | Forward P/E | 6.80 |
| Beta | 1.11 | Short Ratio | 5.04 | Inst. Own | 44.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 4.81 | 200-d Avg | 5.83 | 1yr Est | 6.67 |
SCYNEXIS, Inc. (NASDAQ: SCYX), a clinical-stage biotechnology company advancing novel therapies for
Tuesday's session saw 729 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday